Surgeon’s Role in Manipulating the Microbiome to Improve Outcomes following Cancer Surgery (C)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Cancer. Learn more about ACS Accreditation/Verification Requirements.
Cancer biology is increasingly being recognized as intimately influenced by the community structure, membership, and function of the microbiome local to the tumor environment. Practicing surgeons regularly manipulate the microbiome with the use of antiseptics, nutritional supplements, antibiotics, and bowel preparation solutions. The extent to which these empirical therapies are helpful or harmful is a subject of great controversy. The overall objective of this session is to provide the foundational science and its practical application to both surgeon-scientists and practicing clinicians with the goal of understanding and reducing complications following surgery.
Moderator: John C. Alverdy, MD, FACS, Chicago, IL
Co-Moderator: Benjamin D. Shogan, MD, Chicago, IL
Incorporating Microbiome Sciences in the Surgical Management of Cancer
James M. Kinross, MBBS, FRCS, PhD, London, United Kingdom
Bowel Prep, Diet, and Cancer Recurrence Following Colorectal Surgery: The Role of the Microbiome
Benjamin D. Shogan, MD, Chicago, IL
How Examination of the Gut Microbiome Can Inform the Surgical Management of Pancreatic Cancer
Ryan M. Thomas, MD, FACS, Gainesville, FL
Cancer Cells Shed into the Colon Lumen during Surgery Enhance Their Metastatic Potential in the Presence of Pathogenic Microbes
Ashley J. Williamson, MD, Chicago, IL
Sponsored by the Scientific Forum Committee
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
For questions about the course, please contact firstname.lastname@example.org.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures).
Faculty and Disclosures
Ashley J. Williamson MD - Nothing to Disclose
Benjamin D. Shogan MD - Nothing to Disclose
James M. Kinross, MBBS, FRCS, PhD - Advisory board for Safeheal: Financial renumeration: Consultant; Advisory board for Verb Robotics.: Financial renumeration: Advisor; Consultant for Johnson and Johnson: Financial renumeration: Consultant; Director Getwell Media: Shares: Company director; Director Renegade Medical: Shares: Company director
John C. Alverdy MD, FACS - Nothing to Disclose
Ryan M. Thomas MD, FACS - Nothing to Disclose
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure
David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure
Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit